🇺🇸 FDA
Patent

US 11987610

T-cell modulatory multimeric polypeptides and methods of use thereof

granted A61KA61K2039/505A61K2039/55533

Quick answer

US patent 11987610 (T-cell modulatory multimeric polypeptides and methods of use thereof) held by Cue Biopharma, Inc. expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cue Biopharma, Inc.
Grant date
Tue May 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/505, A61K2039/55533, A61K35/17, A61K38/00